|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Entrenched Knowledge Structures and ConsumerResponse to New Products显示文摘 | MOREAU C P LEHMANN D R MARKMAN AB | 2001 | Journal of MarketingResearch2001，38，1： | 1 |
| 2 | Innovation speed: Transferring university technology to market显示文摘 | Markman G Phan P Balkin D | 2008 | Research Policy2008，34，7： | 1 |
| 3 | Entrepreneurship from the ivory tower:do incentive systems matter?显示文摘 | Markman G D Gianiodis P T Phan P H | 2004 | The Journal of Technology Transfer2004，29，： | 1 |
| 4 | Supply-Side Innovation and Technology Commercialization 显示文摘 | Markman G D Gianiodis P T Phan P H | 2009 | Journal of Manage- ment Studies2009，46，4： | 1 |
| 5 | Supply-side Innovation and Technology Commercialization显示文摘 | Markman G D Gianiodis P T Phan P H | 2009 | Journal of Management Studies2009，46，4： | 1 |
| 6 | Entrepreneurship from the ivory tower: Do incen- tive systems matter ? 显示文摘 | Markman G D Gianiodis P T Phan P H Balkin D B | 2004 | The Journal of Technolo- gy Transfer2004，29，34： | 1 |
| 7 | Phase 2 trial of carboplatin, paclitaxel, and irinotecan in ovarian, fallopian tube, and primary peritoneal cancers 显示文摘 | Eseobar P F Markman M Rose P | 2004 | Gyneeol Oncol2004，92，1： | 1 |
| 8 | Atrial septal defect in the middle aged and elderly显示文摘 | Markman P Howitt G Wade EG | 1965 | Q J Med1965，34，： | 1 |
| 9 | Entrepreneurship and university-based 4 technology transfer显示文摘 | MARKMAN G D PHAN P H BALKIN D B GIANIODIS PT | 2005 | Journal of Business Venturing2005，20，2： | 1 |
| 10 | Entrenched Knowledge Structures and Consumer Response to New Products 显示文摘 | Moreau C P Lehmann D R Markman A B | 2001 | Journal of Marketing Research2001，38，1： | 1 |
| 11 | Entrepreneurship from the ivory tower:Do incentive systems matter?显示文摘 | MARKMAN G D GIANIODIS P T HAN P H | 2004 | The Journal of Technology Transfer2004，29，34： | 1 |
| 12 | A phase Idoseescalation study of the safety,pharmacokinetics andpharmacodynamics of XL-765,a novel inhibitor of PI3Kand mTOR,administered orally to patients with solidtumors显示文摘 | Markman B Lurusso P M Patnaik A | 2008 | Eur J Cancer Suppl2008，6，12： | 1 |
| 13 | Intraperitoneal paelitaxei:a possible role in the managenment of ovarian cancer显示文摘 | MARKMAN M FRANCIS P ROWINSKY E | 1995 | Semin Oncol1995，22，： | 1 |
| 14 | Entrepreneurship and university-based technology transfer显示文摘 | MARKMAN G PHAN P H BALKIN D B and | 2005 | Journal of Business Venturing2005，20，： | 1 |
| 15 | Significance of early changes in the serum CA-125 antigen level on overall survival in advanced ovarian cancer显示文摘 | Markman M Federico M Liu P Y | 2006 | Gynecol Oncol2006，103，1： | 1 |
| 16 | Pretreatment CA-125 and risk of relapse in advanced ovarian cancer显示文摘 | Markman M Liu P Y Rothenberg M L | 2006 | J Clin Oncol2006，24，9： | 1 |
| 17 | Phase 2 trial of carboplatin, paclitaxel, and irinotecan in ovarian, fallopian tube, and primary peritoneal cancers 显示文摘 | Escobar PF Markman M Rose P et d | 2004 | Gynecol Oncol2004，92，1： | 1 |
| 18 | Atrial septal defect in the middle-aged and elderly显示文摘 | Markman P Howitt G Wade EG | 1965 | Q J Med1965，34，136： | 1 |
| 19 | Innovation speed: Transferring university technology to Market显示文摘 | Markman G Phan P Balkin D | 2005 | Research Policy2005，34，7： | 1 |
| 20 | Entrepreneur- ship and university-based technology transfer 显示文摘 | MARKMAN G D PHAN P H BALKIN D B etc | 2005 | Journal of Business Venturing2005，，20： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员